RxDoctor Payments Data

Brittany Polizzi

Adult Health · Encinitas, CANPI 1821692336

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (38.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Lilly USA, LLC at 59.1% of the total. Among adult health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,706in general payments, 2019–2025

Across 496 payments — averaging $69.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$20K
  • AbbVie$5K
  • E.r. Squibb & Sons, L.L.C.$2K
  • EPI Health, LLC$984
  • Sanofi$943
  • Arcutis Biotherapeutics, Inc.$687
  • plus $5K from 22 others

What the payments were for

  • Consulting fees$6,18218%
  • Speaking & faculty fees$13,21338%
  • Travel & lodging$2,8658%
  • Food & beverage$12,13835%
  • Education$3091%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,706 in reported general payments places this provider in the 95th percentile of 785 adult health providers in California.

See all adult health providers in California

Medicare billing

Part B allowed, 2024
$127,590
Medicare patients
352
Services billed
2,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil97$5,732
Ketoconazole197$2,670
Doxycycline Hyclate26$1,985
Metronidazole32$1,482
Tacrolimus12$1,447
Clobetasol Propionate49$1,239
Triamcinolone Acetonide84$736
Fluocinonide31$733
Ciclopirox38$701
Clindamycin Phosphate17$477
Betamethasone Dipropionate13$410
Mupirocin48$362
Nystatin18$207
ValacyclovirValacyclovir Hcl16$187
Cephalexin28$150

Paid to pharmacies, not to this prescriber.

Other adult health in Encinitas

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →